Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Which Tools Better Predict Fall Risk in Parkinson's Disease: A Comparative Study of Objective, Self-Reported, and Functional Balance Assessment

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Introduction: Falls are common in Parkinson's disease (PD), affecting 30-90% of patients annually, with more than half experiencing recurrent falls. Identifying balance assessment tools that are both practical and predictive of fall risk is therefore essential. This study aimed to investigate the relationship between fall frequency and three balance assessment tools: the Biodex Balance System (objective), the Falls Efficacy Scale-International (FES-I) (self-reported), and the Mini-Balance Evaluation Systems Test (Mini-BESTest) (functional). Methods: Patients with PD at Hoehn and Yahr stages 1-3 will be included in the study. Fall data will be collected using a fall diary, while objective balance will be assessed with the Biodex Balance System, functional performance will be evaluated with the Mini-BESTest, and self-reported balance confidence will be measured with the FES-I.

Who May Be Eligible (Plain English)

Who May Qualify: - Age between 40 and 80 years old - Receiving stable dopaminergic treatment - No other neurological disorders besides PD - A Standardized Mini-Mental State Examination (MMSE) score \>24 - Hoehn and Yahr stage between 1-3 - Voluntarily agreed to participate in the study after receiving detailed information Who Should NOT Join This Trial: Presence of visual, hearing impairments, cardiovascular or pulmonary diseases that could affect study outcomes - Having mental or physical impairments severe enough to hinder communication - Clinically unstable condition within the past month - Participation in a rehabilitation program within the last six months Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Age between 40 and 80 years old * Receiving stable dopaminergic treatment * No other neurological disorders besides PD * A Standardized Mini-Mental State Examination (MMSE) score \>24 * Hoehn and Yahr stage between 1-3 * Voluntarily agreed to participate in the study after receiving detailed information Exclusion Criteria: Presence of visual, hearing impairments, cardiovascular or pulmonary diseases that could affect study outcomes * Having mental or physical impairments severe enough to hinder communication * Clinically unstable condition within the past month * Participation in a rehabilitation program within the last six months

Locations (1)

Bezmialem Vakif University
Istanbul, Eyup, Turkey (Türkiye)